Rainbow Children's Medicare Q2 FY27 Unaudited Results Approved

Rainbow Children's Medicare Ltd announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results, along with the Limited Review Report from S.R. Batliboi & Associates LLP. Key financial highlights for the quarter include Revenue from operations of ₹4,869.91 Million and Profit after tax of ₹998.65 Million. For the half-year, Revenue from operations stood at ₹8,975.38 Million and Profit after tax was ₹1,704.06 Million. The company also noted progress on its Employee Stock Option Scheme 2025, with 58,260 options granted and 2,131 exercised during the period. Significant business developments include the execution of definitive transaction documents for a new hospital in Malad, Mumbai, through its subsidiary, and the acquisition of a 64% partnership interest in Super Prime Medical Care LLP.